NSCLC Stage IV trials recruiting in Arkansas

Fewer than 3 recruiting trials found.

All NSCLC Stage IV trials nationally

Cities in Arkansas

Recruiting trials in Arkansas

• Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
  NCT06745908 · Phase: Phase 3 · Ages: 18 Years to 90 Years · Sex: All (male and female) · Arkansas: Springdale